150 related articles for article (PubMed ID: 27060276)
21. Pharmacokinetics and ex-vivo pharmacodynamics of cefquinome against Klebsiella pneumonia in healthy dogs.
Zhang B; Gu X; Li X; Gu M; Zhang N; Shen X; Li Y; Ding H
J Vet Pharmacol Ther; 2014 Aug; 37(4):367-73. PubMed ID: 24372291
[TBL] [Abstract][Full Text] [Related]
22. PK-PD integration and modeling of marbofloxacin in sheep.
Sidhu PK; Landoni MF; Aliabadi FS; Lees P
Res Vet Sci; 2010 Feb; 88(1):134-41. PubMed ID: 19523661
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys.
Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
Vet Res Commun; 2006 Oct; 30(7):775-89. PubMed ID: 17004040
[TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetics of valnemulin in swine.
Zhao DH; Zhang Z; Zhang CY; Liu ZC; Deng H; Yu JJ; Guo JP; Liu YH
J Vet Pharmacol Ther; 2014 Feb; 37(1):59-65. PubMed ID: 23617793
[TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile.
Odenholt I; Walder M; Wullt M
Chemotherapy; 2007; 53(4):267-74. PubMed ID: 17595541
[TBL] [Abstract][Full Text] [Related]
26. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection.
Xiao XM; Xiao YH
Acta Pharmacol Sin; 2008 Oct; 29(10):1253-60. PubMed ID: 18817632
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and pharmacodynamics of isopropoxy benzene guanidine against
Lu Y; Yang L; Zhang W; Li J; Peng X; Qin Z; Zeng Z; Zeng D
Front Vet Sci; 2022; 9():1004248. PubMed ID: 36246309
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in calves.
Sidhu PK; Landoni MF; Aliabadi MH; Toutain PL; Lees P
J Vet Pharmacol Ther; 2011 Aug; 34(4):376-87. PubMed ID: 21091727
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial activity of lupulone against Clostridium perfringens in the chicken intestinal tract jejunum and caecum.
Siragusa GR; Haas GJ; Matthews PD; Smith RJ; Buhr RJ; Dale NM; Wise MG
J Antimicrob Chemother; 2008 Apr; 61(4):853-8. PubMed ID: 18276602
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.
Waraich GS; Sidhu PK; Daundkar PS; Kaur G; Sharma SK
J Vet Pharmacol Ther; 2017 Oct; 40(5):429-438. PubMed ID: 27943295
[TBL] [Abstract][Full Text] [Related]
32. Mutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves.
Ramalingam B; Sidhu PK; Kaur G; Venkatachalam D; Rampal S
J Vet Pharmacol Ther; 2015 Dec; 38(6):529-36. PubMed ID: 25776301
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and ex vivo pharmacodynamics of cefquinome in porcine serum and tissue cage fluids.
Zhang BX; Lu XX; Gu XY; Li XH; Gu MX; Zhang N; Shen XG; Ding HZ
Vet J; 2014 Mar; 199(3):399-405. PubMed ID: 24423605
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic/pharmacodynamic relationship of enrofloxacin against Aeromonas hydrophila in crucian carp (Carassius auratus gibelio).
Shan Q; Wang J; Wang J; Ma L; Yang F; Yin Y; Huang R; Liu S; Li L; Zheng G
J Vet Pharmacol Ther; 2018 Dec; 41(6):887-893. PubMed ID: 29943470
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic-pharmacodynamic modeling and simulation for in vivo bactericidal effect in murine infection model.
Katsube T; Yamano Y; Yano Y
J Pharm Sci; 2008 Apr; 97(4):1606-14. PubMed ID: 17705288
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against
Lei Z; Liu Q; Xiong J; Yang B; Yang S; Zhu Q; Li K; Zhang S; Cao J; He Q
Front Pharmacol; 2017; 8():542. PubMed ID: 28871226
[TBL] [Abstract][Full Text] [Related]
37. In Vitro Anaerobic Pharmacokinetic/Pharmacodynamic Model to Simulate the Bactericidal Activity of Levornidazole Against Bacteroides fragilis.
Hu J; Zhang J; Chen Y; Liang W; Wu S
Clin Ther; 2017 Apr; 39(4):828-836. PubMed ID: 28363695
[TBL] [Abstract][Full Text] [Related]
38. Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine
Luo W; Wang D; Qin H; Chen D; Pan Y; Qu W; Huang L; Xie S
J Vet Sci; 2021 Nov; 22(6):e41. PubMed ID: 34854264
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.
Sang K; Hao H; Huang L; Wang X; Yuan Z
Front Vet Sci; 2015; 2():80. PubMed ID: 26779495
[TBL] [Abstract][Full Text] [Related]
40. Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli.
Fuentes F; Izquierdo J; Martín MM; Gomez-Lus ML; Prieto J
Antimicrob Agents Chemother; 1998 Feb; 42(2):414-8. PubMed ID: 9527796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
